Home Your basket
• Major orbital complicatio...
   Price 8.50 €
• Quality of life before an...
   Price 10.50 €
• Chondrocalcinosis of the ...
   Price 8.50 €
• Abscess tonsillectomy for...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• Immunohistochemistry expr...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Central and peripherical ...
   Price 8.50 €
• Bilateral paranasal sinus...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Congenital cholesteatoma ...
   Price 5.50 €
• The «intra-cordal polyp»:...
   Price 5.50 €
• Schwannomas of the neck. ...
   Price 5.50 €
• Construction and validati...
   Price 10.50 €
• Microsurgical reconstruct...
   Price 10.50 €
• Communication disorders m...
   Price 5.50 €
• The effects of pregnancy ...
   Price 14.00 €
• Temporomandibular dysfunc...
   Price 10.50 €
• Hearing preservation in p...
   Price 10.50 €
• Temporary loss of visual ...
   Price 8.50 €
• Thyroid oncocytomas....
   Price 10.50 €
• Learning curve in sialend...
   Price 10.50 €
• Karapandzic flap for reco...
   Price 10.50 €
• Voice rehabilitation afte...
   Price 10.50 €
• The velum: 5th tap of spe...
   Price 14.00 €
• Active bone conduction im...
   Price 12.00 €
• The nasal framework in rh...
   Price 10.50 €
• The silent sinus syndrome...
   Price 12.50 €
• Reconstruction of the ant...
   Price 8.50 €
• Thyroid surgery (356 case...
   Price 10.50 €
• Monolingualism, an overlo...
   Price 5.50 €
• A post-styloid mass revea...
   Price 12.50 €
• Lateral semicircular cana...
   Price 10.50 €
• A clinical respiratory ev...
   Price 10.50 €
• Congenital anomalies of n...
   Price 14.00 €
• Management of cerebellopo...
   Price 10.50 €
• Histology of the larynx....
   Price 8.50 €

Total Order 353.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

PAEDIATRICS

Universal hearing screening in the Champagne-Ardenne regions: Results and consideration after 55 000 births from January 2004 to June 2007


Authors : Langagne T, Schmidt P, Leveque M, Chays A. (Reims)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:153-158.

Article published in french
Downloadable PDF document french



Summary : Aim: This study presents the results of the Universal Newborn Hearing Screening (UNHS) experience in Champagne-Ardenne from January 2004 to June 2007. Materials and methods: A UNHS program was introduced in the entire French region of Champagne-Ardenne in January 2004. Developed upon a strong demand from public and private medical institutions, the program’s aim is the early detection and treatment of bilateral profound or severe hearing loss. The program is composed of 2 steps: the first test is realised in maternity and consists of automated OtoAcoustic Emissions (aOAE). When absent in both ears at first test (positive screening test), the child is referred to a second test 15 days after maternity discharge (aOAE or automated Auditory Brainstem Response (aABR)). If the second test is still failed (positive screening test), the child is referred to a diagnostic procedure (Auditory Brainstem Response) realised by a paediatrician ENT in a reference centre. The UNHS program differs for newborns in Neonatal Intensive Care Units where aABR is realised at first test because of the high frequency of auditory neuropathy in this population. All results are collected in the Regional Neonatal Screening Centre, in charge of the UNHS follow-up. Results: 53 930 newborns benefited from the UNHS program, which represent 98.7% of the 54 790 births in the region during this period. 591 newborns had a positive first test (no aOAE responses) and were referred to the second test. 532 had a negative second test and 46 had a positive second test. 22 children could not have the second test: 4 children deceased, 9 were lost to follow-up (the families moved outside the region) and 9 families refused the second test. The 46 neonates were referred to the diagnostic ABR test and 42 of those 46 babies were diagnosed with neonatal bilateral hearing losses before the age of 6 months. Conclusion: This UNHS experience demonstrates that such UNHS programs are feasible and reliable, at least in a region as wide as Champagne-Ardenne. It achieved to diagnose 42 hearing impaired children, who could benefit from an early intervention for their handicap.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE